Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4434_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •Foreword
- •Foreword
- •Foreword
- •Preface
- •Acknowledgment
- •Contents
- •About the Editors
- •1.1 Introduction
- •1.6 Dissection Procedure
- •1.6.2 Dissection Guide
- •1.9 Conclusion
- •References
- •2.1 Introduction
- •1.5.3 Sentinel Lymph Node Biopsy
- •2.3.1 Oral Cavity Surgery
- •2.3.2 Pharyngeal Surgery
- •2.3.3 Transoral Robotic Surgery (TORS)
- •2.4 Laryngeal Surgery
- •2.6 Salivary Gland Surgery
- •2.7 Thyroid Gland Surgery
- •2.8 Neck Dissection
- •2.9.1 Paediatric Surgery
- •2.10 Anatomical Versus Surgical Landmarks
- •2.13 Conclusion
- •References
- •3.1 Introduction
- •3.6.1 Pharynx
- •3.6.2 Nasopharyngeal Surgery
- •3.6.6 Temporal Bone Surgery
- •3.7 Conclusion
- •References
- •4.2.1 Perineural Tumour Spread
- •4.2.2 Carotid Artery Involvement
- •4.3.1 Oral Cavity
- •4.3.2 Nasopharynx
- •4.3.3 Oropharynx
- •4.3.4 Hypopharynx
- •4.3.5 Larynx
- •4.4.1 Oral Cavity Squamous Cell Carcinoma
- •4.4.2 Oropharyngeal Squamous Cell Carcinoma
- •4.4.3 Nasopharyngeal Squamous Cell Carcinoma
- •4.4.4 Non-HPV Oropharyngeal Squamous Cell Carcinoma
- •4.4.5 Unknown Primary Tumours
- •4.5 Lymph Nodes
- •4.5.1 Introduction
- •4.5.2.1 Clustering
- •4.5.2.2 Morphology
- •4.5.2.3 Inhomogeneity
- •4.5.2.4 Size
- •4.5.2.5 Lymphatic Drainage
- •4.6 Advanced Imaging
- •4.6.1 Elastography
- •4.6.2 DWI-MRI
- •4.7.1 Introduction
- •4.11 Cross-Sectional Imaging
- •References
- •5: Approach Towards Oral Cavity Cancers
- •5.1 Introduction
- •5.3 Diagnostic Evaluation
- •5.8.2.1 Access-Incision Planning
- •5.8.3 Surgical Techniques
- •5.8.3.1 Anaesthesia Considerations
- •5.8.4.1 Peroral Wide Local Excision
- •5.8.5.1 Access Osteotomy Through Mandibulotomy
- •5.8.5.2 Surgical Steps
- •5.8.5.3 Pull-Through Approach
- •5.8.5.4 Oral Component
- •5.8.5.5 Neck Component
- •5.8.6.1 Peroral Wide Local Excision
- •5.8.6.2.1 Surgical Steps
- •5.8.11 Hard Palate (T1–T2 Lesion)
- •5.8.11.1 Upper Alveolectomy
- •References
- •6.1 Benign Oropharyngeal Tumours
- •6.1.1 Lingual Thyroid
- •6.1.2 Epidemiology
- •6.1.3 Clinical Presentation
- •6.1.4 Histology
- •6.1.5 Imaging
- •6.1.6 Blood Investigation
- •6.1.7 Treatment
- •6.1.8 Surgical Treatment
- •6.1.9 Non-surgical Treatment
- •6.2 Pleomorphic Adenoma
- •6.2.1 Diagnosis
- •6.4.8 Early Stage
- •6.4.9 Advanced Stage
- •6.4.10 Non-surgical Treatment
- •6.4.11 Case Illustration 1
- •6.4.12 Case Illustration 2
- •6.5 Benign Hypopharyngeal Tumours
- •6.5.1 Fibrolipoma
- •6.2.3 Treatment
- •6.2.4 Case Illustration 1
- •6.3 Papilloma
- •6.3.1 Epidemiology
- •6.3.2 Clinical Presentation
- •6.3.3 Histology
- •6.3.4 Treatment
- •6.4.1 Risk Factors
- •6.4.2 Clinical Presentation
- •6.4.3 Diagnosis
- •6.4.4 Histology
- •6.4.5 Imaging
- •6.4.6 Staging
- •6.4.7 Treatment
- •6.6.1 Epidemiology
- •6.6.2 Risk Factor
- •6.6.3 Clinical Presentation
- •6.6.4 Diagnosis
- •6.6.5 Blood Investigations
- •6.6.6 Imaging
- •6.6.8 Histology
- •6.6.9 Staging
- •6.6.9.1 Primary Tumour (T)
- •6.6.9.2 Regional Lymph Node (N)
- •6.6.9.3 Distant Metastasis (M)
- •6.6.9.4 Stage Groups
- •6.6.10 Treatment
- •6.6.10.1 Surgical
- •References
- •7.1 Introduction
- •7.2 Salvage Neck Dissection
- •7.3.2.1 Procedure
- •7.3.2.2 Advantages
- •7.3.2.3 Disadvantages
- •7.3.3.1 Procedure
- •7.3.3.2 Advantages
- •7.3.3.3 Disadvantages
- •7.4.1 Procedure
- •7.4.2 Advantages
- •7.4.3 Disadvantages
- •7.5.1 Procedure
- •7.5.2 Advantages
- •7.5.3 Disadvantages
- •7.6 Subtemporal-Preauricular Infratemporal Fossa Approach
- •7.6.1 Procedure
- •7.6.2 Advantages
- •7.6.3 Disadvantages
- •7.7 Facial Translocation
- •7.7.1 Procedure
- •7.7.2 Advantages
- •7.7.3 Disadvantages
- •7.8 Endoscopic Endonasal Transpterygoid Nasopharyngectomy (EETN)
- •7.8.1 Patient Selection
- •7.8.2 Surgical Technique
- •7.8.2.1 Nasoseptal Flap
- •7.8.2.2 Sinonasal Corridor
- •7.8.2.3 Posterior Septectomy
- •7.8.2.4 Inferior Sphenoidectomy
- •7.8.2.5 Transpterygoid Dissection
- •7.8.2.6 Tumour Extirpation
- •7.10 Miscellaneous
- •7.11 Conclusion
- •References
- •8.1 Introduction
- •8.6 Parotid Gland Surgery
- •8.6.1 Benign Parotid Tumour Surgery
- •8.6.2 Malignant Parotid Tumour Surgery
- •8.7.1.2 Skin Incision
- •8.7.1.4 Greater Auricular Nerve Preservation
- •8.7.1.8 Facial Nerve Branch Preservation
- •8.7.1.10 Homeostasis Control
- •8.7.1.12 Post-operative Follow-Up
- •8.7.2.1 Case Illustration 1
- •8.8 Complications Post Parotidectomy
- •8.9.2 Post-operative Assessment
- •8.12 Conclusion
- •References
- •9.1 Introduction
- •9.2.1 Recurrent Laryngeal Nerve
- •9.2.3 Berry’s Ligament
- •9.2.4 Parathyroid Gland Anatomy
- •9.2.5 Inferior Thyroid Artery
- •9.2.6 Zuckerkandl Tubercle
- •9.5 Retrosternal Thyroid Tumour
- •9.7 Intraoperative Neural Monitoring
- •9.9 Thyroid Lobectomy
- •9.9.1 Case Illustration 1: Completion Hemithyroidectomy
- •9.10 Conclusion
- •References
- •10.1 Introduction
- •10.2 Surgical Anatomy
- •10.3 Indications
- •10.4.1 Patient Preparation
- •10.4.2 Informed Consent
- •10.4.3 Preoperative Planning/Evaluation
- •10.4.4.1 Antibiotic
- •10.4.4.2 Systemic Corticosteroid
- •10.4.4.3 Topical Decongestants
- •10.4.4.4 Adrenaline
- •10.4.5 Anaesthesia
- •10.4.7 Image-Guided System (IGS)
- •10.5 Operative Techniques
- •10.5.1 Endoscopic Sinus Surgery
- •10.5.1.1 Uncinectomy
- •10.5.1.2 Middle Meatal Antrostomy (MMA)
- •10.5.1.3 Ethmoidal Bullectomy
- •10.5.1.4 Posterior Ethmoidectomy
- •10.5.1.5 Sphenoidotomy
- •10.5.1.6 Frontal Sinusotomy
- •10.6 Intraoperative Complication
- •10.6.1 Intranasal Complications
- •10.6.1.2 Arterial Injury
- •10.6.1.2.1 Sphenopalatine Artery
- •10.6.1.2.2 Anterior Ethmoidal Artery (AEA)
- •10.6.1.2.3 Posterior Ethmoidal Artery (PEA)
- •10.6.1.2.4 Internal Carotid Artery (ICA)
- •Call for Help
- •Interventional Radiologist/Endovascular
- •10.6.2 Intraorbital Complications
- •10.6.2.2 Orbital Emphysema (Grade I)
- •10.6.2.3 Intraorbital Haematoma (Grade I)
- •10.6.2.5 Extraocular Muscle Injury (Grade III)
- •10.6.2.6 Optic Nerve Injury (Grade III)
- •10.6.3 Intracranial Complications
- •10.6.3.1 CSF Leak
- •10.6.4 Post-operative Complication
- •10.6.4.1 Epistaxis
- •10.6.4.2 Nasal Synechia
- •10.6.4.3 Other Complications
- •References
- •11.1 Introduction
- •11.2 Anatomical Landmarks
- •11.3 Background
- •11.4 Patient’s Preparation
- •11.5 Equipment
- •11.6 Positioning
- •11.7 Preoperative Evaluation
- •11.8 Infrastructure Maxillectomy
- •11.9 Subtotal Maxillectomy
- •11.10 Total Maxillectomy
- •11.12 Transoral-Transnasal Endoscopic Maxillectomy
- •11.13 Endoscopic-Assisted Transfacial Maxillectomy
- •11.14 Conclusion
- •References
- •12.1 Introduction
- •12.3 Laryngeal Diseases
- •12.4 Supraglottic Carcinoma
- •12.5 Glottic Carcinoma
- •12.6 Subglottic Carcinoma
- •12.8 Surgical Treatment
- •12.9.1 Skin Incision
- •12.9.5 Larynx Skeletonization
- •12.10 Open Partial Horizontal Laryngectomy (OPHL)
- •12.10.1.1 Surgical Technique
- •12.10.2.1 Surgical Technique
- •12.10.3.1 Surgical Technique
- •12.11 Total Laryngectomy
- •12.11.1 Surgical Technique
- •12.12 Future Challenges
- •12.13 Conclusion
- •References
- •13.1 Introduction
- •13.5 Central Compartment Neck Dissection
- •13.6 Selective Neck Dissection
- •13.7.1 Selective Neck Dissection
- •13.7.2 Case Illustration 1
- •13.7.3 Case Illustration 2
- •13.7.4 Case Illustration 3
- •13.9 Radical Neck Dissection
- •13.11 Prognosis
- •13.12 Conclusion
- •References
- •14.1 Introduction
- •14.3 Endoscopic Assisted Surgical Access
- •14.3.1 Endoscopic Thyroidectomy
- •14.7 Clavicle Osteotomy
- •14.7.1 Case Illustration
- •14.7.1.1 Case 1
- •14.8 Base-of-Neck Tumour
- •14.11 Conclusion
- •References
- •15.1 Introduction
- •15.2 Orbital Exenteration
- •15.2.1 Surgical Steps
- •15.2.1.1 Lid-Sparing Exenteration
- •15.2.1.2 Total Exenteration
- •15.2.2 Case Illustrations
- •15.2.3 Complications
- •15.4 Conclusion
- •References
- •16.1 Introduction
- •16.2.1 Benign Pathology
- •16.4 Vestibular Disorders
- •16.4.1 Ménière’s Disease
- •16.4.2 Superior Semicircular Canal Dehiscence
- •16.5.3 Temporal Bone Paraganglioma
- •16.6 Malignant Neoplasms
- •16.7.1 Diagnostic Audiology
- •16.7.2 Vestibular Tests
- •16.7.3 Imaging
- •16.8.2 Postauricular Incision
- •16.8.3 Transmeatal Incisions
- •16.8.4 Endaural Incisions
- •16.9 Anterior Atticotomy
- •16.10 Transmastoid Approaches
- •16.10.3 Posterior Tympanotomy
- •16.11 Endolymphatic Sac Decompression
- •16.12 Subtotal Petrosectomy
- •16.13 Translabyrinthine Approaches
- •16.14 Transcochlear Approach
- •16.16 Middle Cranial Fossa
- •16.19 Endoscopic Ear Surgery
- •16.19.1 Protympanum
- •16.19.2 Epitympanum
- •16.19.3 Retrotympanum
- •16.19.4 Hypotympanum
- •16.21 Conclusion
- •References
- •17.1 Introduction
- •17.2.1 Vascular Lesions
- •17.2.2 Infantile Haemangioma
- •17.2.2.1 Introduction
- •17.2.2.2 Epidemiology
- •17.2.2.3 Pathogenesis
- •17.2.2.4 Phases
- •17.2.2.4.1 Proliferative Phase
- •17.2.2.4.2 Involution Phase
- •17.2.2.5 Diagnosis
- •17.2.2.6 Treatment
- •17.2.2.7 Medical Therapy
- •17.2.2.8 Laser Therapy
- •17.2.2.9 Surgical Therapy
- •17.2.3 Dermoid Cyst
- •17.2.3.1 Introduction
- •17.2.3.3 Clinical Presentation
- •17.2.3.4 Imaging
- •17.2.3.5 Treatment
- •17.2.3.5.1 Surgery
- •17.3 Thyroglossal Duct Cyst
- •17.3.1 Introduction
- •17.3.2 Embryology
- •17.3.3 Clinical Presentation
- •17.3.4 Diagnosis
- •17.3.4.1 Blood Investigation
- •17.3.4.3 Histology
- •17.3.4.4 Imaging
- •17.3.5 Treatment
- •17.3.5.1 Surgery
- •17.3.5.2 Sclerotherapy
- •17.4 Rhabdomyosarcoma
- •17.4.1 Introduction
- •17.4.3 General Characteristics
- •17.4.4 Histology
- •17.4.5 Diagnosis
- •17.4.5.1 Biopsy
- •17.4.6 Staging
- •17.4.7 Treatment
- •17.4.7.1 Chemotherapy
- •17.4.7.2 Radiation Therapy
- •17.4.7.3 Surgical Therapy
- •17.4.8 Prognosis
- •17.4.9 Recurrence
- •17.5.1 Introduction
- •17.5.2 Epidemiology
- •17.5.3 Aetiology
- •17.5.4 Pathogenesis
- •17.5.5 Presentation
- •17.5.6 Diagnosis
- •17.5.7 Imaging
- •17.5.8 Histology
- •17.5.9 Staging
- •17.5.9.1 Fisch Staging
- •17.5.9.2 Radkowski Staging
- •17.5.10 Treatment
- •17.5.10.1 Surgery
- •17.5.10.2 Outcome
- •17.5.10.3 Complications
- •17.5.10.4 Radiotherapy
- •17.5.10.5 Chemotherapy
- •17.5.10.6 Hormonal Therapy
- •17.5.10.7 Spontaneous Regression
- •17.6 Lymphatic Malformation
- •17.6.1 Introduction
- •17.6.2 Genetics
- •17.6.3 Clinical Presentation
- •17.6.4 Diagnosis
- •17.6.5 Treatment
- •17.6.5.1 Observation
- •17.6.5.2 Sclerotherapy
- •17.6.5.3 Surgery
- •17.6.5.4 Other Modalities
- •17.6.5.4.1 Novel Agents
- •17.7 Cystic Hygroma
- •17.8 Lymphoma
- •17.8.1 Hodgkin’s Lymphoma
- •17.8.2 Non-Hodgkin’s Lymphoma
- •17.8.4 Diagnosis
- •17.8.4.1 Haematology
- •17.8.4.2 Imaging
- •17.8.4.3 Surgery
- •17.8.7.1 Radiation Therapy
- •17.9 Langerhans Cell Histiocytosis
- •17.9.1 Epidemiology
- •17.9.2 Pathogenesis
- •17.9.3 Clinical Feature
- •17.9.4 Investigations
- •17.9.5 Treatment
- •17.9.5.1 Solitary or Single-System Involvement
- •17.9.5.2 Multisystem Involvement
- •17.9.5.3 Induction Chemotherapy
- •17.9.5.4 Continuation Chemotherapy
- •17.9.5.5 Post-treatment Follow-Up
- •17.9.5.6 Relapsed or Refractory Disease
- •References
- •18.1.1 Case Illustration 1
- •18.1.2 Surgical Steps
- •18.2 Case Illustration 2
- •18.3 Stomatoplasty
- •18.5.1 Case Illustration
- •18.6.1 Case Illustration
- •18.7 Deep Lobe Parotidectomy
- •18.8 Conclusion
- •References
- •19.1 Introduction
- •19.2.1 Cross-Sectional Imaging
- •19.2.2 Emerging Applications
- •19.2.6 PET-MR
- •19.2.8 Others
- •19.2.8.1 SPECT
- •19.2.8.2 Elastography
- •19.2.8.3 Fluoroscopy
- •19.2.8.4 Narrowband Imaging
- •19.2.9 Biochemical Investigations
- •19.2.10 Imaging Biomarkers
- •19.3.1 Neck Dissection
- •19.5 Oral Cavity Cancer (OCSCC)
- •19.7 Hypopharyngeal Cancer
- •19.8 Nasopharynx Carcinoma (NPC)
- •19.10 Salivary Gland Malignancy
- •19.10.1 Parotid Tumors
- •19.11 Intraoperative Facial Nerve Monitoring
- •19.12.1 Treatment
- •19.13 Parapharyngeal Space Tumors (PPS)
- •19.14.2 Diagnostic Controversy
- •19.14.5 Optimal Resection Margins
- •19.15.1 Nonsurgical Treatment
- •19.16.2 Induction Chemotherapy
- •19.19.1 Targeted Therapy
- •19.19.2 Immunotherapy
- •19.19.3 Cancer Stem Cells (CSCs)
- •19.20 Conclusion
- •References

13 Neck Dissections inHead andNeck Malignancy
Fig. 13.17 Selective neck dissection is completed. The
IJV (star), common carotid artery (white arrow), and
vagus nerve (black arrow) are visible
335
Fig. 13.19 The outline of modied Weber-Ferguson is
marked, and ipsilateral neck dissection skin incision follows the primary tumour excision line
Fig. 13.18 The en bloc dissection specimen measuring
7.0cm × 4.0cm
13.7.3 Case Illustration 2
This is a case of maxillary sinus ca T4N1MO
planned for extended left maxillectomy and left
anterolateral SND.The mass occupies the whole left
maxilla area with extension to the infraorbital region.
The skin incision is designed as in Figs.13.19 and
13.20. The modied Weber- Ferguson skin incision
is used for total maxillectomy.
The cut on the skin, subcutaneous tissue, and
platysma can be made with a blade or a cautery.
The small blood vessels can be coagulated
instantly with cautery. If big anterior facial vein is
present, it can be clipped or ligated. The platysma
muscle can be identied as thin bres extending
from mandible to clavicle. It can be cut, and the
plane beneath the muscle is used to lift the skin
ap superiorly (Figs.13.21 and 13.22).
The tissue is cut by using a blade size 11 or a
ne cautery (with a Colorado tip). This ensures a
Fig. 13.20 The outline of skin incision for maxillectomy
and ipsilateral orbital exenteration
Fig. 13.21 A subplatysmal skin ap is raised superiorly
till the level of mandible and inferiorly till clavicular level.
This exposes level I, II, III, and IV neck for the brofatty
tissue removal
ne cutting of the tissue layer by layer. The dissection is started at level Ia and continues with level
IB where submandibular gland is visualized.

336
N. Mat Lazim
Fig. 13.22 Dissection starts at levels Ia and IB.The tissue at level Ia is held with Allis tissue forceps and retracted
inferiorly to ease the dissection
Fig. 13.23 Dissection at level Ib addressing the removal
of submandibular gland and its nodes. Branches of facial
artery and vein need to be ligated
The marginal mandibular nerve can be identied as it runs supercial to the submandibular
gland capsule. The use of microsurgical loupes
and nerve stimulator facilitates the marginal
mandibular nerve identication and preservation.
The facial artery and vein need to be ligated
twice, anterior and posterior to the glands
(Fig. 13.23). Once the submandibular gland is
released just underneath the mandible, it can be
retracted down as the dissection continues.
Retraction of mylohyoid muscle superomedially
exposes the lingual nerve, submandibular nerve,
and hypoglossal nerve (Figs.13.24 and 13.25).
The dissection continues at levels III and IV
(Fig.13.26). The fascia overlying the IJV is dissected in continuity with the fascia overlying the
carotid artery. This exposes the carotid artery and
vagus nerve (Figs.13.27 and 13.28). The lower
Fig. 13.24 The submandibular gland is removed together
with the brofatty tissue of neck dissection specimen
Fig. 13.25 The anterior and posterior belly of digastric
muscle is well visualized once the submandibular gland
has been retracted inferiorly
Fig. 13.26 The dissection continues inferiorly at level III
and IV neck. This patient has a thin neck and not much of
the brofatty tissue is visualized apart from the thin
fascia
end of the IJV can be identied by using omohyoid muscle. The vein lies intimately deep to the
muscle (Fig.13.29). This is used if dissection is

13 Neck Dissections inHead andNeck Malignancy
337
Fig. 13.27 Dissection continues to expose the carotid
sheath and its content (IJV, vagus nerve, common carotid
artery)
Fig. 13.28 Dissection on the fascia over carotid artery is
done, and the tissue is medialized
Fig. 13.30 The branch of IJV is retracted medially to
facilitate dissection
Fig. 13.31 Left recurrent parotid tumour (arrow) on the
maxilla, with minimal subcutaneous tissue and possible
skin inltration. The tumour is abutting the masseter muscle (M). The difference in parotid region can be appreciated, where the parotid gland is still visualized (RP) with
haziness in the region. The left parotid area is replaced
with fatty tissue (LP), as the patient already had left total
parotidectomy before
Fig. 13.29 The omohyoid is a critical landmark for the
identication of IJV
started inferiorly, and retrograde dissection is
performed. The branches of IJV can be retracted
and preserved during dissection (Fig. 13.30).
This reduces post-operative facial oedema.
13.7.4 Case Illustration 3
A 45-year-old Malay male with a history of
parotidectomy for acinic cell carcinoma in 2013.
Now, the patient re-presented with a recurrent
tumour at left zygoma. The tumour measures
2.0cm × 1.0cm, is mobile, and lies quite supercial, just underneath the skin at the zygoma
(Figs.13.31 and 13.32). The facial nerve examinations showed grade II left marginal mandibular
nerve paresis. CT scan image showed a heterogenous mass with irregular border abutting the
zygoma (Fig.13.31).

338
Patient is planned for excision of left cheek
recurrent tumour together with selective neck
dissection at left level II–IV neck nodes.
The patient lies supine with neck hyperextended. The facial nerve stimulator is applied. The
area is cleaned with dilute povidone iodine solution. Oral intubation is performed, and the tube is
anchored to the right side of the mouth (Fig.13.32).
A modied Blair skin incision is performed
(Fig.13.33). The skin ap is raised anteriorly to
the level of the recurrent tumour to facilitate excision and clearance of the tumour with free surgical margin. Frozen section of tissue is carried out
to ensure negative surgical margins. The skin
superior to the mass is tense and thin but mobile.
The nerve stimulator is used to identify the
facial nerve branches, which blend with brotic
tissue due to previous surgery (Fig.13.34). The
anterior limit of skin ap is at the anterior border
of the recurrent tumour to allow visualization and
extirpation of tumour.
The branches of the facial nerve are away
from the tumour, thus allowing easy dissection
and removal of the tumour tissues. A good cuff of
periphery tissue surrounds the tumour which is
resected to ensure the adequacy of the surgical
margins (Figs.13.35 and 13.36).
Anterolateral neck dissection of ipsilateral left
level I, II, III, and IV is carried out. All brofatty and
lymphatic tissue from level Ia, Ib, II, III, and IV is
dissected out (Figs.13.37, 13.38, 13.39, and 13.40).
N. Mat Lazim
Fig. 13.33 A modied Blair skin incision has been done.
The subplatysmal skin ap is raised (arrow), exposing the
sternocleidomastoid muscle (star) underneath
Fig. 13.34 The skin ap (white star) is retracted and
reected anteriorly exposing the whitish parotid bed
(black star) and sternocleidomastoid muscle (arrow)
Fig. 13.32 Surgical landmarks are drawn: the outline of
tumour margin (star), the inferior angle of mandible
(arrow), and the modied Blair skin incision (MB). The
drape exposes the angle of mouth and eyes to monitor
contraction of the muscle during dissection
Fig. 13.35 The recurrent tumour (star) is retracted gently
laterally, and deep tissue dissection is continued. The sternocleidomastoid muscle (arrow) will be rotated to cover
the surgical defect post tumour removal

13 Neck Dissections inHead andNeck Malignancy
Sternocleidomastoid muscle is cut at its upper
one-third and half of its width, and rotated
supero-anteriorly to cover the defect caused by
removal of recurrent tumour (Fig. 13.41). This
enhances the post-op cosmesis, which is impaired
if there is presence of cheek depression.
Post-operatively, the patient had signicant
facial nerve paralysis, especially the marginal
mandibular nerve grade III House-Brackmann
grading system (Fig.13.42).
339
Fig. 13.38 Spinal accessory nerve (star) runs supercial
to IJV and extends obliquely inferiorly to innervate the
SCM
Fig. 13.36 The excised recurrent tumour measuring
4.8cm × 3.0cm which is solid and hard in consistency
Fig. 13.37 The SCM is retracted lateral inferiorly, and
the brofatty tissue (star) inferior to mandible is dissected
and retracted inferiorly. The brofatty tissue (star) over
the IJV is dissected, while traction is maintained
inferiorly
Fig. 13.39 The IJV and common carotid artery (CCA)
are visualized medial to the sternocleidomastoid muscle
(SCM). The brofatty tissue has been cleared and removed
exposing the inferior border of mandible (M)
Fig. 13.40 The neck dissection specimen is labelled with
suture to orientate for the histopathological examination

340
Fig. 13.41 The sternocleidomastoid muscle is rotated
superior anteriorly (star) and sutured to subcutaneous tissue. IJV, common carotid artery (CCA), and digastric tendon (DT) are visualized
N. Mat Lazim
Fig. 13.42 Left marginal mandibular nerve paralysis (arrow) evident as loss of depression of left lower lip. Postoperative wound (star) and a drain are secured (arrow) in situ on the left neck
13.8 Modied Radical Neck
Dissection
The skin incision methods of MRND which
are commonly used include:
1. J incision or hockey stick incision
MRND is performed for neck metastasis disease with clinically signicant palpable neck
nodes. The MRND will address level I–V neck
2. Modied Gluck-Sorenson
3. U-shape incision
4. MacFee incision
nodes with or without preservation of the three
non- lymphatic structures. The classication of
neck dissection is shown in Table13.5.

13 Neck Dissections inHead andNeck Malignancy
b
e
341
h
Steps of MRND
1. Patient preparation, and patient lies supine
with neck extension and face turned to the
contralateral side.
2. Skin is draped and cleaned with dilute povi-
done iodine.
3. Skin marking and surgical landmarks are
drawn with marker pen and tattooing done at
the skin incision, to ensure asymmetry
closure.
4. Skin incision is carried out with blade size 12;
a subplatysmal skin is raised superiorly till

342
Table 13.5 Classication of types of modied radical
neck dissection (MRND)
Type of
MRND Description
1. MRND
type I
2. MRND
type II
3. MRND
type III
Dissection of lymphatic tissues and
brofatty tissues at level I–V neck
nodes with preservation of spinal
accessory nerves
Dissection of lymphatic tissues and
brofatty tissues at level I–V neck
nodes with preservation of spinal
accessory nerves and IJV
Dissection of lymphatic tissues and
brofatty tissues at level I–V neck
nodes with preservation of spinal
accessory nerves, IJV, and SCM
N. Mat Lazim
Fig. 13.44 The dissection at level V is carried out. The
SCM muscle has to be retracted medially. The SAN needs
to be identied and skeletonized along its course from
SCM to trapezius muscle
Fig. 13.43 Dissection at levels II, III, and IV will show
the IJV from mandibular level to clavicle level. The SCM
is reected laterally
mandible, inferiorly till clavicle, and posteriorly till anterior trapezius muscle.
5. Dissection starts at level Ia and Ib of the neck.
6. Dissection continues to levels II, III, and IV
overlying the internal jugular vein (Fig.13.43).
7. Dissection at level V is performed, with the
identication and preservation of SAN. The
SCM is maintained retracted laterally
(Fig.13.44).
8. Further dissection at level V exposed the metastatic nodes (Fig.13.45).
9. Spinal accessory nerve is identied and preserved (Fig.13.46).
In this case, a clavicle osteotomy is required in
order to remove the metastatic neck nodes with
negative margins. This widened the surgical
Fig. 13.45 Metastatic neck node dissection at levels V
and IV necessitates clavicular osteotomy to facilitate
dissection
Fig. 13.46 Spinal accessory nerve is running from the
posterior border of sternocleidomastoid to the anterior
border of trapezius

13 Neck Dissections inHead andNeck Malignancy
343
access and allowed better manipulation of the
adjacent IJV and vagus nerve in order to reduce
iatrogenic injury to these vital structures. Lower
dissection in the infraclavicular region also added
the risk of lymphatic duct injury with resultant
chylous leak.
In some forms of head and neck cancer, the
total number of harvested lymph nodes (nodal
yield) in a neck dissection specimen is an independent prognostic factor [12]. For patients who
are clinically N1b, the American Thyroid
Association (ATA) recently issued recommendations for a modied radical neck dissection
(MRND) encompassing levels II–V. Only a few
studies have compared the outcomes of the ipsilateral and bilateral MRND clinicopathologic
characteristics. The author reported that patients
who had a thyroidectomy and bilateral MRND
had a better outcome [13].
13.9 Radical Neck Dissection
In our practice, radical neck dissection is rarely
performed due to multiple factors. This factor
mainly involves the patient’s factors and tumour’s
factors. Many imperative patients’ factors need to
be considered before embarking on a radical neck
dissection, as the complications which can occur
post-operatively are very high. All these complications impair the patient’s quality of life postoperatively. Additionally, a thorough
understanding of the anatomy of the neck is
essential to avoid injury to vital structures when
performing radical neck dissection. The complicated anatomical relations of the various nerves,
vessels, and muscles within the conned area of
the neck can often be daunting especially for
junior surgeons [14]. Unless the surgeons are
well versed with the anatomic details, variations,
and intraoperative ndings, the complications are
unavoidable.
In our practice, the majority of patients that
present to us with neck metastases who are indicated for radical neck dissection are elderly
patient population with multiple comorbidities.
In addition to poor cardiopulmonary reserve,
these patients also have other comorbidities such
as hypertension and a history of cardiac events
like angina, myocardial infarction, and stroke.
This places this category of patients as poor surgical candidates.
Consideration of benet versus risk is mandatory when deciding for the best surgical treatment
intended for any head and neck cancer patients.
The treatment outcomes need to outweigh the
morbidity from the surgery. The radical neck dissection causes signicant sequelae that can
impair the patient’s quality of life postoperatively. The effectiveness of radical neck dissection would not be questioned if the treatment
outcomes would be perfect. When post-operative
morbidity is associated with oncological shortage
of radical neck dissection, either in functional or
cosmesis embarrassment, other alternative therapeutic approaches should be considered [15].
13.10 Post-operative Care
andComplications
Neck dissection is a fairly morbid operation.
Many of the critical head and neck structures are
at risk during the surgery. The complication, disturbance, and interruption to these organs’ functions are so critical since they interfere with
breathing, swallowing, neck movement, or shoulder abduction. In the past decades wherein radical neck dissection has been more frequently
practised, the section of sternocleidomastoid
muscle, spinal accessory nerve, and internal jugular vein causes a very debilitating post-operative
sequelae. This includes facial oedema, frozen
shoulder syndrome, thin neck and limited neck,
and shoulder mobility. The long hours of surgery
also cause more bleeding, tissue injury, increased
post-operative drainage, and prolonged postoperative recovery. All of these complications
signicantly impair the patient’s quality of life.
The sternocleidomastoid muscle, internal jugular vein, spinal accessory nerve, submandibular
gland, and cervical plexus nerves used to be sacriced during radical neck dissection. This was
practised for decades as the standard operative
procedure in the surgical management of lymph
node metastases of head and neck cancers [16].

344
N. Mat Lazim
As severe complications related to the surgery
began to be experienced by patients who have
undergone RND with minimal increment in
disease- free survival, many centres investigated
the role of less extensive neck dissection which
has a comparable treatment outcome. In this current era, more types of functional neck dissection
have been introduced and practised. Numerous
studies have shown that these types of neck dissection are more efcient with less surgeryrelated morbidities but patients have similar
prognosis and survival rates.
Quality of life of a head and neck oncology
patient is severely affected by the surgery. Selected
patients require multiple surgeries due to recurrent tumours. This causes more detrimental complications, which are challenging to manage,
especially in elderly patient group who have multiple medical comorbidities. The brotic tissue
due to the initial surgery makes the identication
of neurovascular structures more difcult with
more risk of nerve palsies and bleeding. Shoulder
dysfunction and discomfort, loss of sensitivity of
the overlying skin, cranial nerve damage, and anatomic deformities are all common side effects of
this operation, all of which have an impact on the
patient’s quality of life [17]. Thus, it is imperative
to properly plan a neck dissection with meticulous
techniques and practices during the dissection and
a committed team should be involved for every
head and neck oncology case.
When more neck node levels are dissected,
more complications can be expected. This is
especially true when neck node level V is
addressed for a MRND or RND.Selected clinicians agree on the fact that level V dissection will
result in less morbidity. On the other hand, maintaining such lymph node levels may result in a
higher rate of regional failure, necessitating further care with re-surgery or combination of surgery and radiation, and likely resulting in a poorer
prognosis [17]. In essence, it should be thoroughly assessed whether level V neck dissection
should be incorporated or omitted during neck
dissection for a primary tumour that has a potential of spread to this level.
The complication that arises from surgery is
not only due to the direct transection of the neural
structures or puncture to the big vessels. It can
also arise from techniques of dissection, instrument used, assistant error, or inappropriate traction applied during the dissection. Shoulder
complaints and functional impairment are common sequelae of neck dissection. This is often
attributed to injury of the spinal accessory nerve
by aggressive dissection or direct trauma.
Nevertheless, shoulder morbidity may also occur
in cases in which the spinal accessory nerve has
been preserved [16]. This is mainly due to overmanipulation or traction applied during the dissection. Reported neck dissection surgery
complications of spinal accessory nerve injury
include decreases in the power and range of
motion of the shoulder muscle, drooping shoulder, and shoulder pain [18].
In some centres, the spinal accessory nerve
injury is signicant as more MRND is performed
since the majority of patients present with signicant palpable neck node disease. Many symptoms and signs have been discussed and
associated with SAN injury in the literatures.
Trapezius paralysis or dysfunction, shoulder girdle depression, trapezius atrophy, scapular dyskinesia, failure of shoulder abduction, and shoulder
and neck pain are all symptoms of spinal accessory nerve injury. Detecting these related symptoms is usually enough to make a diagnosis of
spinal accessory nerve palsy [16].
The prevalence and incidence of dysfunction
of the shoulder and neck following neck dissection vary according to the type of operation performed. Preoperative education for patients
undergoing neck dissection should include
informing the patients that the risk of developing
musculoskeletal complications is reduced but not
eliminated by SAN preservation [19]. The
research data conrms that shoulder morbidity is
increased by clearance of the posterior triangle of
the neck [20].
Higher shoulder mobility, less loss of face and
neck sensation, and better quality of life are associated with the preservation of cervical root
branches of the cervical plexus following a functional neck dissection in which the spinal accessory nerve is spared [18, 21]. Shoulder
dysfunction was the most common side effect in
Соседние файлы в папке Библиотека им академика М.И. Перельмана
